Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients - Quast, D R; Schneider, R; Burdzik, E; Hoppe, S; Möslein, G (Fam Cancer, 2016)